Multiple Sclerosis: Current Status and Strategies for the Future

Print

Cover Image

HARDBACK
$57.95

Download

Table of Contents
Front Matter R1-R18
Executive Summary 1-16
1 Introduction 17-28
2 Clinical and Biological Features 29-114
3 Characteristics and Management of Major Symptoms 115-176
4 Disease Management and Measurement 177-240
5 Strategies for Future Research on Disease Mechanisms 241-276
6 Future Strategies for Therapies 277-324
7 Building and Supporting the Research Enterprise 325-346
8 Recommendations 347-368
Appendix A: Committee and Staff Biographies 369-376
Appendix B: List of Expert Consultants 377-378
Appendix C: Workshop Agendas 379-384
Appendix D: Kurtze's Expanded Disability Status Scale 385-386
Appendix E: Drugs Used in the Treatment of MS 387-400
Appendix F: U.S. Social Security Administration's Criteria for Qualifying as Disabled from MS 401-404
Appendix G: Treatments That Have Been Claimed to Be of Benefit in MS 405-412
Index 413-438

View/Hide Left Panel

Page 382

Workshop on Quality of Life

February 23-24, 2000
National Academy of Sciences Building
Washington, D.C.

Agenda

Wednesday, February 23
9:30-10:15 am	Michael Weinrich NIH, NICHD, National Center for Rehabilitation Research	Rehabilitation Research Strategies
10:15 am	BREAK
10:30-11:15 am	Barbara Vickrey UCLA	Measuring the Quality of Life
11:15 am - 12:00 pm	Deborah Miller Cleveland Clinic and Chair, MS Clinical Care Guidelines Committee	The Development and Role of Clinical Care Guidelines
12:00 pm	LUNCH
Thursday, February 24
11:15 am - 12:00 pm	Mindy Aisen Rehabilitation Research and Development Service, Department of Veterans Affairs	Research to Maximize Function in MS Patients: Rehabilitation and Beyond

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement